4//SEC Filing
Wahl Bryan 4
Accession 0001841401-24-000001
CIK 0001819790other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 5:45 PM ET
Size
7.7 KB
Accession
0001841401-24-000001
Insider Transaction Report
Form 4
Wahl Bryan
General Counsel
Transactions
- Award
Stock Option (right to buy)
2024-03-07+42,500→ 42,500 totalExercise: $35.50Exp: 2034-03-06→ Common Stock (42,500 underlying) - Award
Restricted Stock Units
2024-03-07+28,702→ 28,702 total→ Common Stock (28,702 underlying)
Footnotes (3)
- [F1]25% of the option shares shall vest on March 7, 2025, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027, and 2028, subject to the Reporting Person's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001841401
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 5:45 PM ET
- Size
- 7.7 KB